Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
EXX
0.00%
0.0¢
Expose Resources Limited
Currently unlisted.
Proposed listing date: WITHDRAWN
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
EXX | IPO - Expose Resources Limited | 25/05/19 | 16 | 9.8K | |||
|
See All Discussions